Tonix Pharmaceuticals Holding Corp. (TNXP) | Stock price, performance, AI analysis | Thematic | AI powered fundamental research and development platform

Loading...

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

|

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

Follow our journey and product updates

Product

Research a topic Stock screener Find companies Search for securities Load an existing portfolio Backtest

Learn

Thematic overview Develop asset-backed products Company evaluations Backtesting and benchmarking Thematic branded indices Build investment strategies with crypto

Company

How to use About us Blog

Tonix Pharmaceuticals Holding Corp. (TNXP)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Company performance

Current Price

as of Jan 16, 2025

$0.23

P/E Ratio

N/A

Market Cap

$43.92M

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Metrics

Overview

HQChatham, NJ
SectorHealth Technology
IndustryPharmaceuticals: Major
TickerTNXP
Price$0.235+1.16%

Trading Information

Market cap$43.92M
Float100.00%
Average Daily Volume (1m)139,831,165
Average Daily Volume (3m)107,406,127
EPS-$20.56

Company

Revenue$11.29M
Rev growth (1yr)-29.26%
Net income-$14.21M
Gross margin27.18%
EBITDA margin-533.45%
EBITDA-$15.05M

EV-$10.32M
EV/Revenue-0.91
P/EN/A
P/S1.29
P/B0.49

Documents

SEC Filings

8-K (2025-01-08)

8-K (2024-12-23)

8-K (2024-12-20)

8-K (2024-12-17)

8-K (2024-12-03)

8-K (2024-11-13)

8-K (2024-11-12)

8-K (2024-11-08)

8-K (2024-11-04)

8-K (2024-11-01)

8-K (2024-10-30)

8-K (2024-10-28)

8-K (2024-10-17)

8-K (2024-10-16)

8-K (2024-10-08)

8-K (2024-09-27)

8-K (2024-09-23)

8-K (2024-09-19)

8-K (2024-09-16)

8-K (2024-09-10)

8-K (2024-09-09)

8-K (2024-09-06)

8-K (2024-08-30)

8-K (2024-08-29)

8-K (2024-08-26)

8-K (2024-08-20)

8-K (2024-08-19)

8-K (2024-08-12)

8-K (2024-08-09)

8-K (2024-07-30)

8-K (2024-07-25)

8-K (2024-07-16)

8-K (2024-07-10)

8-K (2024-07-08)

8-K (2024-07-01)

8-K (2024-06-28)

8-K (2024-06-26)

8-K (2024-06-20)

8-K (2024-06-13)

8-K (2024-06-10)

8-K (2024-06-06)

8-K (2024-06-03)

8-K (2024-05-30)

8-K (2024-05-22)

8-K (2024-05-21)

8-K (2024-05-13)

8-K (2024-04-01)

8-K (2024-03-29)

8-K (2024-03-25)

8-K (2024-03-21)

8-K (2024-03-20)

8-K (2024-03-19)

8-K (2024-03-11)

8-K (2024-03-07)

8-K (2024-03-06)

8-K (2024-03-05)

8-K (2024-02-28)

8-K (2024-02-27)

8-K (2024-02-15)

8-K (2024-02-13)

8-K (2024-02-12)

8-K (2024-01-31)

8-K (2024-01-29)

8-K (2024-01-25)

8-K (2024-01-19)

8-K (2024-01-08)

8-K (2024-01-02)

8-K (2023-12-21)

8-K (2023-12-20)

8-K (2023-12-12)

8-K (2023-12-08)

8-K (2023-12-04)

8-K (2023-11-15)

8-K (2023-11-13)

8-K (2023-11-09)

8-K (2023-11-02)

8-K (2023-10-31)

8-K (2023-10-30)

8-K (2023-10-26)

8-K (2023-10-20)

8-K (2023-10-19)

8-K (2023-10-18)

8-K (2023-10-16)

8-K (2023-10-04)

8-K (2023-09-29)

8-K (2023-09-27)

8-K (2023-09-25)

8-K (2023-09-21)

8-K (2023-09-18)

8-K (2023-09-14)

8-K (2023-09-11)

8-K (2023-09-06)

8-K (2023-09-05)

8-K (2023-08-21)

8-K (2023-08-16)

8-K (2023-08-10)

8-K (2023-08-07)

8-K (2023-08-01)

8-K (2023-07-31)

8-K (2023-07-28)

8-K (2023-07-27)

8-K (2023-07-26)

8-K (2023-07-24)

8-K (2023-07-17)

8-K (2023-07-12)

8-K (2023-07-10)

8-K (2023-07-03)

8-K (2023-06-26)

8-K (2023-06-15)

8-K (2023-06-13)

8-K (2023-06-07)

8-K (2023-06-05)

8-K (2023-06-01)

8-K (2023-05-31)

8-K (2023-05-25)

8-K (2023-05-23)

8-K (2023-05-22)

8-K (2023-05-17)

8-K (2023-05-09)

8-K (2023-05-08)

8-K (2023-05-05)

8-K (2023-05-04)

8-K (2023-05-01)

8-K (2023-04-19)

8-K (2023-04-17)

8-K (2023-04-13)

8-K (2023-04-06)

8-K (2023-04-05)

8-K (2023-04-04)

8-K (2023-03-30)

8-K (2023-03-23)

8-K (2023-03-20)

8-K (2023-03-16)

8-K (2023-03-13)

8-K (2023-03-07)

8-K (2023-02-27)

8-K (2023-02-23)

8-K (2023-02-13)

8-K (2023-02-09)

8-K (2023-02-07)

8-K (2023-02-06)

8-K (2023-02-02)

8-K (2023-02-01)

8-K (2023-01-31)

8-K (2023-01-30)

8-K (2023-01-26)

8-K (2023-01-25)

8-K (2023-01-24)

8-K (2023-01-10)

8-K (2023-01-04)

10-Q (2024-11-12)

10-Q (2024-08-16)

10-Q (2024-05-13)

10-Q (2023-11-09)

10-Q (2023-08-10)

10-Q (2023-05-08)

10-K (2024-04-01)

10-K (2023-03-13)

Factset Street Account

Tonix Pharmaceuticals' TNX-1800 selected by NIH/NIAID project NextGen for inclusion in clinical trials ($0.49, 0.00) (2023-11-02T12:14:09Z)

Tonix Pharmaceuticals reports Q3 EPS ($1.83) vs FactSet ($1.49) [3 est, ($1.66)-(1.17)] ($0.47, 0.00) (2023-11-09T21:42:43Z)

Tonix Pharmaceuticals provides overview of TNX-2900 at the Foundation for Prader-Willi Research Family Conference ($0.56, 0.00) (2023-10-09T11:03:38Z)

Tonix Pharmaceuticals completes clinical stage of Phase 3 RESILIENT study of TNX-102 SL for the management of fibromyalgia ($0.46, 0.00) (2023-11-15T12:10:46Z)

Tonix Pharmaceuticals completes clinical stage of Phase 2 prevention study of TNX-1900 for the prevention of migraine headaches in chronic migraineurs ($0.55, 0.00) (2023-10-26T11:06:45Z)

Tonix Pharmaceuticals announces presentation of new data involving TNX-1500 in heart xenotransplantation in animal models ($0.55, 0.00) (2023-10-30T11:09:58Z)

Tonix Pharmaceuticals announces Enrollment initiated in Mass General Brigham phase 2 study of TNX-1900 for bone health in children with autism spectrum disorder ($0.47, 0.00) (2023-11-13T12:15:30Z)

Tonix announces publication of data in the Journal Nature Involving TNX-1500 (Fc-modified dimeric anti-CD40L mAb) for the prevention of rejection in kidney xenotransplantation in animal models ($0.57, 0.00) (2023-10-18T11:06:38Z)

Ask a question